Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Soft Tissue Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03282344
What this trial is testing

NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Who this might be right for
SARCOMA
Memorial Sloan Kettering Cancer Center 88
Testing effectiveness (Phase 2)Study completedNCT02453191
What this trial is testing

TVEC and Preop Radiation for Sarcoma (4 ml Dose)

Who this might be right for
Soft Tissue Sarcoma
University of Iowa 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694871
What this trial is testing

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Who this might be right for
Advanced Dedifferentiated LiposarcomaLocally Advanced Dedifferentiated LiposarcomaMetastatic Dedifferentiated Liposarcoma+3 more
Alliance for Clinical Trials in Oncology 77
Very early researchWithdrawnNCT04877587
What this trial is testing

Gemcitabine With Ascorbate Including Adolescents

Who this might be right for
Soft Tissue SarcomaBone SarcomaUnresectable Soft Tissue Sarcoma+3 more
David Dickens
Early research (Phase 1)Study completedNCT02122861
What this trial is testing

Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1

Who this might be right for
Melanoma - Currently EnrollingNon-small Cell Lung Cancer - Enrollment CompletedSarcoma - Enrollment Completed
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Testing effectiveness (Phase 2)Study completedNCT05301764
What this trial is testing

LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Lyvgen Biopharma Holdings Limited 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836571
What this trial is testing

Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

Who this might be right for
Locally Advanced Extraskeletal Myxoid ChondrosarcomaLocally Advanced LeiomyosarcomaLocally Advanced Liposarcoma+7 more
National Cancer Institute LAO 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT06660810
What this trial is testing

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

Who this might be right for
Soft Tissue SarcomaSarcoma,Soft Tissue
John Rieth 2
Large-scale testing (Phase 3)Looking for participantsNCT06345729
What this trial is testing

Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 600
Not applicableStudy completedNCT00253708
What this trial is testing

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Cancer
Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00659360
What this trial is testing

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult FibrosarcomaAdult LeiomyosarcomaAdult Liposarcoma+12 more
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Ended earlyNCT02929394
What this trial is testing

Trabectedin Maintenance Post 1st-line in STS

Who this might be right for
Sarcoma, Soft Tissue
European Organisation for Research and Treatment of Cancer - EORTC 13
Testing effectiveness (Phase 2)Study completedNCT00104949
What this trial is testing

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

Who this might be right for
Sarcoma
SWOG Cancer Research Network 40
Testing effectiveness (Phase 2)Study completedNCT00085475
What this trial is testing

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 17
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04599062
What this trial is testing

TVEC and Preop Radiation for Sarcoma (8 ml Dose)

Who this might be right for
Soft Tissue Sarcoma
John Rieth 8
Early research (Phase 1)Study completedNCT03150810
What this trial is testing

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
BeiGene 139
Testing effectiveness (Phase 2)Ended earlyNCT05026736
What this trial is testing

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Who this might be right for
Locally Advanced AngiosarcomaMetastatic AngiosarcomaRecurrent Angiosarcoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT04765228
What this trial is testing

Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma

Who this might be right for
Stage III Adult Soft Tissue Sarcoma
Yong Chen 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Next Page